Cardiologist. AsistProf McGill,Former Imaging Fellow @ClevelandClinic. Prez, Canadian Society of MRI. Interested in Cardiac Amyloid and Pericardial diseases.
Joined March 2016
- Tweets2.4K
- Following741
- Followers1.1K
- Likes6.9K
RT @CSEchoCa: Congratulations to the 2026 CSE annual achievement award recipient Dr. Sharon Mulvagh!
The CSE Annual Achievement Award, pre…
Michael Chetrit retweeted
🆕 ACC Scientific Statement on Exercise Prescriptions For CV Health in Adults provides practical, evidence-based guidance to help clinicians confidently prescribe exercise across a wide range of CV conditions.
Read the full Scientific Statement ➡️ bit.ly/4hxfedX #JACC
Michael Chetrit retweeted
🚨Don't miss CSE sessions at the CCC!
Today's talks (October 15th):
- CSE SPOTLIGHT – PFO IN CLINICAL PRACTICE: WHEN TO LOOK, WHEN TO CLOSE AND WHEN TO WALK AWAY
8:30 AM – 9:30 AM
Room: 208
- ECHOCARDIOGRAPHIC INSIGHTS: WHAT NOT TO MISS IN ADULT CONGENITAL HEART DISEASE
11:30 AM – 12:30 PM
Room: 208
- TREAT FIRST, CONFIRM LATER? A PRACTICAL APPROACH TO RECOGNIZING AND TREATING IMMUNE CHECKPOINT INHIBITOR MYOCARDITIS
2:00 PM – 3:00 PM
Room: 208
- CARDIO-OBSTETRIC NIGHTMARES
3:30 PM – 4:30 PM
Room: 208
#CVultrasound #CSE #CCS #CCC2026 #Echocardiography
Honored to receive the #Wiesman Award for Excellence in ATTR-CM research with @ekoikonomou at #HFSA2026.
Thanks to @Cornerstone_CME, @ionispharma, @AstraZeneca for supporting this initiative.
The future of early detection is in good hands!
Michael Chetrit retweeted
Honored to receive the #Wiesman Award for Excellence in ATTR-CM research with @ChetritMichael at #HFSA2026.
Shared @CarDS_Lab work on multimodal #AI integration across ECG, echo, CT & EHR data for a digital ATTR-CM screening pathway.
Thanks to @rohan_khera for his mentorship, and @Cornerstone_CME, @ionispharma, @AstraZeneca for supporting this initiative.
Michael Chetrit retweeted
Jim Januzzi presented on a novel TTR and NTproBNP ratio metric --> excellent surrogate marker
Simultaneously published in JACC
jacc.org/doi/10.1016/j.jchf.…
#HFSA2026
#MedIQHFSA2026
Michael Chetrit retweeted
We presented the ASCEND ATTR trial dedign. CMR/Echo/biomarkers study of acoramidis in patients with ATTR-CM. The trial is actively recruitng
clinicaltrials.gov/study/NCT…
#HFSA2026
#MedIQHFSA2026
Michael Chetrit retweeted
What are the characteristics of patients who switch from tafamidis to acoramidis in claims data?
#HFSA2026
#MedIQHFSA2026
Michael Chetrit retweeted
Thank you to all the Young Investigators who submitted their #ATTR abstracts! The 3rd Annual Forum boasts another stellar group of physician-scientists.
Co-Chair scoring begins next week! The Final Four will present their work for $100,000 on October 29th.
Michael Chetrit retweeted
Abstract submissions are hitting the queue!
...is yours next?
24 hours until the deadline. $100,000 in #ATTR #research funding is at stake.
Don't wait! Submit here: cornerstonemeded.com/attr-ec…
Michael Chetrit retweeted
The time has come! 14 hours left.
Submit your abstract TODAY to compete for $100,000 in #ATTR #research funding and a chance to join the #Wiesman legacy.
Abstract submission link:
cornerstonemeded.com/attr-ec…
Michael Chetrit retweeted
Excellent news for our patients and their families
Mavacamten is now FDA approved for pediatric patients with oHCM (weight >/= 30 kg / 66 lb) based on the SCOUT-HCM trial
fda.gov/drugs/news-events-hu…
Michael Chetrit retweeted
This is the LAST WEEKEND before the deadline!
$100,000 in #ATTR #research funding awaits.
Submit here (it takes less than 5 minutes):
cornerstonemeded.com/attr-ec…
Michael Chetrit retweeted
2 weeks. $100,000 in #amyloid research funding.
Submit your #ATTR abstract in less than 5 minutes at the link below - it could change the rest of your career.
Deadline: Friday, October 2nd at 11:59 PM ET.
cornerstonemeded.com/attr-ec…
Michael Chetrit retweeted
3 WEEKS REMAIN.
Where could your #ATTR research take you?
Present your work. Get feedback from leaders in the field. Build new scientific connections. Compete for one of two $100K #Wiesman Awards.
Don’t wait. Submit now!
cornerstonemeded.com/attr-ec…
Deadline: Friday, October 2nd
Michael Chetrit retweeted
Diagnostic Accuracy of Fat Pad Sampling and Bone Marrow Biopsy for AL Amyloidosis: A Systematic Review and Meta-Analysis ashpublications.org/bloodadv…
Michael Chetrit retweeted
@MasriAhmadMD, @MorieGertz, @Ron_Witteles, Dr. Noel Dasgupta, and Dr. Sami Khella are ready for your research!
1 MONTH left to submit for the 3rd Annual #ATTR Early-Career Research Forum. ⏰
Deadline: Oct. 2
2 $100K Wiesman Awards 🏆
Submit here: cornerstonemeded.com/attr-ec…
Michael Chetrit retweeted
Watch Dr. Margot Davis and Dr. Ahmad Masri discuss takeaways from CARDIO-TTRansform at #ESCCongress here: imedicus.ca/BreakingNewsfrom…
Sign up for more daily updates here: surveymonkey.com/r/BreakingN…
Michael Chetrit retweeted
There is no one who has contributed 2 care of ICI-M patients as much as @DrJESalem! Must read for any cardiologist & anyone in #CardioOnc! ICI Myocarditis and Myotoxicity! @CircAHA @bradleymaronmd @HeartDocSadiya @kejoynt @AHAScience @ESCardioOnco ahajournals.org/doi/full/10.…
Michael Chetrit retweeted
MUSIC-HFpEF trial: Intracoronary gene therapy with AAV1.SERCA2a normalized cardiac filling pressures of HFpEF patients through 12 months, demonstrating target engagement and restoration of calcium handling. Download slides here: clinicaltrialresults.org/wp-…
